Main Menu

Professor Janet Shipley

Group Leader

The alt text
Professor Janet Shipley is investigating ways to improve the treatment of patients with sarcomas that have a poor outcome. Group: Sarcoma Molecular Pathology ORCID 0000-0001-6748-8678


Originally from Newcastle upon Tyne, Janet Shipley obtained a BSc (Hons) in Biology from Southampton University and a PhD from the University of London.

See all news stories on our website that feature the work of Professor Shipley and colleagues.

Read news

She has previously worked in the DNA Repair Group at the Paediatric Research Unit at Guy's Hospital in London, the Genetics Division of Harvard at Children's Hospital in Boston, USA and the Imperial Cancer Research Fund UK (which became the London Research Institute and is now part of The Francis Crick Institute).

Professor Shipley moved to The Institute of Cancer Research, London, to establish a laboratory characterising genetic rearrangements in tumours and was awarded tenure in 1996 and a readership in 2003. She has authored more than 160 peer-reviewed manuscripts.

Her current research is focused on identifying molecular markers of high-risk in young onset sarcomas and understanding associated molecular mechanisms in order to derive novel treatments for these patients.

Research advances are taken forward to potential benefit of patients through her membership of the National Cancer Research Institute (NCRI) Clinical Studies Young Onset Sarcoma Subgroup (YOSS) and her Chairmanship of the Biological Committee for the European paediatric Soft tissue sarcoma Study Group (EpSSG). She also sits on the Research Advisory Board of the charity Sarcoma UK and the editorial board of a number of journals. 

Janet was featured in a New Scientist article entitled Finding the love of your life in a cancer lab.